About Summit Autonomous
Summit Autonomous is a Healthcare company based in Waltham (United States) founded in 1985, and was acquired by Alcon in May 2000. Excimer laser systems are developed for correcting vision disorders. Its chief executive, as recorded, is Michael Ball. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its competitors include Clerio Vision, IntraLase and Lenticular Research Group; 3 of its 3 listed competitors have raised funding.
Company details
Summit Autonomous was founded in 1985 in Waltham, United States, focusing on the ophthalmology sector. Excimer laser systems are developed by the company to address vision disorders including nearsightedness, farsightedness, and astigmatism. Contact lenses and additional vision products are also offered. The company was acquired by Alcon in May 2000, integrating its operations into broader medical device activities.
- Headquarters Waltham, United States
- Stage Acquired
- SectorsHealthcare
- Website summit-autonomous.com
- Acquired by Alcon (May 2000)
Investors in Summit Autonomous
Summit Autonomous has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Alcon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | alcon.com | Fort Worth, United States |
Investor details for Summit Autonomous
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Summit Autonomous
1 people are tracked at Summit Autonomous (1 in leadership).
| Name | Role | Group |
|---|---|---|
Michael Ball | CEO | Leadership |
Complete people profiles for Summit Autonomous
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Summit Autonomous
2 dated milestones of Summit Autonomous across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Summit Autonomous is founded.
- Exit Acquired by Alcon.
Competitors of Summit Autonomous
Summit Autonomous has 3 listed competitors in our database, 3 of them funded. They include Clerio Vision, IntraLase and Lenticular Research Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cleriovision.com | 2014 | Rochester, United States | $28.95M | 90 | Laser induced change in refractive index | |
| intralase.com | 1997 | Irvine, United States | $29.5M | Femtosecond laser technology is developed for eye surgery procedures. | ||
| lenticularresearchgroup.com | 2007 | Naperville, United States | $330,000 | Developer of laser device for treating the cause of presbyopia |
Detailed competitors of Summit Autonomous
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Ophthalmology
3 companies that operate in the same segment as Summit Autonomous (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Summit Autonomous
Summit Autonomous was founded in 1985.
Summit Autonomous is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Michael Ball is the CEO of Summit Autonomous, as recorded in our data.
Summit Autonomous was founded in 1985 in Waltham, United States, focusing on the ophthalmology sector. Excimer laser systems are developed by the company to address vision disorders including nearsightedness, farsightedness, and astigmatism. Contact lenses and additional vision products are also offered. The company was acquired by Alcon in May 2000, integrating its operations into broader medical device activities.
Summit Autonomous's top competitors include Clerio Vision, IntraLase and Lenticular Research Group.
Summit Autonomous has 1 investor. Key investors include Alcon.
Yes. Summit Autonomous was acquired by Alcon in May 2000.